Partnerships and collaborations like Tricog’s and GE HealthCare’s or between stakeholders across the healthcare ecosystem ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Tenecteplase in recent years outpaced alteplase as the stroke thrombolytic of choice at one large hospital system, despite ...

1. In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), ...

Of STEMI patients who were transferred between hospitals, only four per cent were relocated within 30-minute target time ...

Germany: A recent cohort study published in JAMA Network Open has shed light on the comparative outcomes of ticagrelor and ...

Patients with adrenal insufficiency had worse outcomes than those without adrenal insufficiency when hospitalized for STEMI. Among patients with ST elevation myocardial infarction (STEMI), comorbid ...

A new study supports previous data demonstrating the superiority of prasugrel over ticagrelor in reducing the composite ...

Researchers have reported better long-term results of coronary artery bypass grafting (CABG) than of percutaneous coronary ...

AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 g/dL for the ...

When Floyd Moro, a 35-year-old Belizean farmer, suffered a heart attack, he was saved by an Atrium Health Sanger Heart & ...

The presence and clinical significance of hepatic tissue alterations as assessed by cardiac magnetic resonance imaging in patients with ST-segment–elevation myocardial infarction (STEMI), are unclear.